A replay of the earnings webcast will be accessible on Resmed’s investor relations website and available approximately two hours after the webcast. In addition, a phone replay will be available ...
If you want to know who really controls ResMed Inc. , then you'll have to look at the makeup of its share registry. With 69% stake, institutions possess the maximum shares in the ...
Zacks Investment Research on MSN
Here's why ResMed (RMD) is a strong growth stock
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few ...
Barchart on MSN
What you need to know ahead of ResMed's earnings release
ResMed Inc. (RMD), headquartered in San Diego, California, manufactures, distributes, and markets medical devices and ...
Lessons learned from implementing in AI at regulated medical device manufacturer, ResMed. This includes top 5 challenges and ...
ResMed is on a mission to cement the lead it’s built while competitor Philips has been out of the CPAP machine-making game. That process of building out its market share for the long-term has recently ...
Medical equipment maker ResMed will pay $37.5 million to resolve allegations brought by the Department of Justice (DOJ) that it paid kickbacks to durable medical equipment suppliers, sleep labs and ...
ResMed plans to sign a lease for an about 446,500-square-foot building on Collins Road in Greenwood. The company is seeking a nearly $500,000 three-year tax break from the Greenwood City Council.
ResMed reported $1.28 billion in revenue and $2.43 EPS, driven by strong demand for AirSense 11 and effective cost management. Rising awareness of sleep apnea, aided by wearable devices like Apple ...
ResMed achieved double-digit revenue and profit growth over the past 9 years, driven by continuous acquisitions and improving operating efficiencies. ResMed's capital efficiencies showed mixed results ...
ResMed (NYSE: RMD), a medical equipment company, has seen an 18% fall in a month, underperforming the broader S&P500 index, up 1%. The recent fall can be attributed to its downbeat Q4 fiscal 2023 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results